Trial Profile
Efficacy of Duloxetine for VIPN (Vincristine-Induced Peripheral Neuropathy) Treatment
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 14 Aug 2018
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 02 Aug 2018 Status changed from recruiting to discontinued.
- 06 Apr 2015 New trial record